CoQ10 (ubiquinol vs ubiquinone) and blood pressure

What 2 graded rows on coq10 (ubiquinol vs ubiquinone) agree on for blood pressure, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the CoQ10 (ubiquinol vs ubiquinone) page, with its PubMed record.

Your question

Supplement
CoQ10 (ubiquinol vs ubiquinone) Choose another

CoQ10 (ubiquinol vs ubiquinone) and blood pressure

2 rows · 1,881 people

Split. 1 row found an improvement and 1 found no difference.

No difference
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade B× 1
  • Grade C× 1
Rows
2
Trials
28
People
1,881
Pooled reviews may count some twice

Where they differ

From the rows
Trial sizeWhen publishedGrade

The best-graded row, grade B, is a meta-analysis of 1,831 people (2022) and found an improvement.

The row that found an improvement was larger: 1,831 people, against 50 people for the row that found no difference.

The row that found an improvement is newer (2022) than the row that found no difference (2016).

The best grade is B among the row that found an improvement, and C among the row that found no difference.

The rows

1 improved · 1 no difference
  1. Grade BSystolic blood pressure in cardiometabolic disease · Improved

    Meta-analysis, 26 studies · n 1,831 · 2022 · Adults with cardiometabolic disorders (such as diabetes and dyslipidemia) in 26 randomized trials

    Varied; about 100 to 200 mg/day gave the largest systolic fall in the dose-response analysis · Varied across trials

    Systolic blood pressure fell by 4.77 mm Hg (95% CI −6.57 to −2.97; moderate certainty); the evidence for diastolic pressure was low certainty. Falls were larger in diabetes and dyslipidemia and in trials longer than 12 weeks.

    Row on the CoQ10 (ubiquinol vs ubiquinone) page · PubMed 36130103 (opens PubMed)

  2. Grade CBlood pressure · No difference

    Meta-analysis, 2 studies · n 50 · 2016 · 2 double-blind RCTs in adults with primary hypertension

    Varied across trials · At least 3 weeks

    No significant change in systolic (-3.68 mm Hg) or diastolic (-2.03 mm Hg) blood pressure; authors judged the evidence moderate quality for no clinically significant effect.

    Row on the CoQ10 (ubiquinol vs ubiquinone) page · PubMed 26935713 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.